Talk to Sam
+1 (805) 652 26 26
» View Public Reports1-2 of 2 reports for CytRx
... Licensed-out to: cytrx corporation (usa) preparation preparation hematologic malignancies hematologic malignancies potent inhibitor of bcr-abl and lyn tyrosine kinases. Possibly ef_fective in imatinib ...
... With increased efficacy and reduced side effects. Ns-187 (bafetinib) b-cell chronic lymphoid leukemia chronic myeloid leukemia (pii preparation) nippon shinyakupii licensed-out to: cytrx corporation (usa ...
Reportlinker.com © Copyright 2014. All rights reserved.